Geode Capital Management’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $26.8K | Sell |
|
|||||
2023
Q3 | $33.2K | Buy |
|
|||||
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $53.4K | Sell |
|
|||||
2022
Q4 | $54K | Buy |
|
|||||
2022
Q3 | $64K | Buy |
|
|||||
2022
Q2 | $20K | Sell |
|
|||||
2022
Q1 | $158K | Buy |
|
|||||
2021
Q4 | $342K | Hold |
|
|||||
2021
Q3 | $674K | Sell |
|
|||||
2021
Q2 | $962K | Sell |
|
|||||
2021
Q1 | $2.57M | Buy |
|
|||||
2020
Q4 | $3.16M | Buy |
|
|||||
2020
Q3 | $3.15M | Buy |
|
|||||
2020
Q2 | $2.81M | Buy |
|
|||||
2020
Q1 | $1.09M | Buy |
|
|||||
2019
Q4 | $1.06M | Buy |
|
|||||
2019
Q3 | $333K | Hold |
|
|||||
2019
Q2 | $410K | Hold |
|
|||||
2019
Q1 | $424K | Buy |
|
|||||
2018
Q4 | $132K | Buy |
|
|||||
2018
Q3 | $68K | Hold |
|
|||||
2018
Q2 | $91K | Buy |
|
|||||
2018
Q1 | $440K | Hold |
|
|||||
2017
Q4 | $460K | Hold |
|
|||||
2017
Q3 | $764K | Hold |
|
|||||
2017
Q2 | $642K | Sell |
|
|||||
2017
Q1 | $644K | Buy |
|
|||||
2016
Q4 | $666K | Buy |
|
|||||
2016
Q3 | $796K | Buy |
|
|||||
2016
Q2 | $671K | Buy |
|
|||||
2016
Q1 | $525 | Buy |
|
|||||
2015
Q4 | $573K | Hold |
|
|||||
2015
Q3 | $387K | Buy |
|
|||||
2015
Q2 | $453K | Buy |
|
|||||
2015
Q1 | $378K | Buy |
|
|||||
2014
Q4 | $173K | Hold |
|
|||||
2014
Q3 | $205K | Buy |
|